Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
202
days
Cellular adhesion-dependent 3D morphogenesis indicating brain tumor aggressiveness and chemosensitivity in spherical cavity culture
Authors
Thuy Huynh; Jieun Kim; Sarnai Amartumur; Inhee Choi; Ji Yeoun Lee; Luke P. Lee; Chaejeong HeoShow moreShow less
Affiliations
1. Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University, Suwon, Republic of Korea; 2. Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, Republic of Korea; 3. Department of Life Science, Department of Chemistry, University of Seoul, Seoul, Republic of Korea; 4. Division of Pediatric Neurosurgery, Seoul National University Children’s Hospital, Seoul, Republic of Korea; 5. Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, USA; 6. Korea Biomedical Institute for Global Health Research and Technology (K-BIGHEART), Pohang University of Science and Technology (POSTECH), Gyeongbuk, Republic of KoreaShow moreShow less
151
days
The spatial and multi-omic landscape of Down syndrome leukemogenesis: moving beyond cellular heterogeneity
Authors
Edoardo Peroni; Rosario Amato; Martina Bado; Mosè Favarato; Antonio RosatoShow moreShow less
Affiliations
1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. UOC Genetica Medica, Azienda Ospedaliera Universitaria Dulbecco, Università Magna Graecia, Catanzaro, Italy; 3. Lab. Immuno-Genetica, Dpt. Scienze della Salute, Università degli Studi “Magna Graecia” di Catanzaro, Catanzaro, Italy; 4. Dipartimento di Direzione Medica del Presidio Ospedaliero di Mestre, UOSD Genetica e Citogenetica, Venice, Italy; 5. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, ItalyShow moreShow less
62
days
Emerging agents and regimens for myeloproliferative neoplasms: updates from ASH 2025 Annual Meeting
Authors
Tiantian Zhang; Heng Jiang; Delong LiuShow moreShow less
Affiliations
1. Department of Internal Medicine, University of Central Florida, Pensacola, USA; 2. Chinese American Hematologist and Oncologist Network (CAHON), Milwaukee, USA; 3. Division of Hematology and Oncology, Department of Internal Medicine, Westchester Medical Center/New York Medical College, Valhalla, USAShow moreShow less
146
days
Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs
Authors
Edoardo Peroni; Marco Pizzi; Marco Basso; Alessandro Atanasio; Elisabetta Calistri; Michele Gottardi; Antonio RosatoShow moreShow less
Affiliations
1. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy; 2. Department of Medicine-DIMED, Surgical Pathology and Cytopathology Unit, Padua University Hospital, Padua, Italy; 3. Pharmacy, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy; 4. Onco-Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy; 5. Department of Surgery Oncology and Gastroenterology, University of Padova, Padova, ItalyShow moreShow less
67
days
Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK + ALCL
Authors
Guiming Li; Jun Wang; Shiguang Ye; Lixin Zhou; Yanli Sun; Bowen Li; Yunshuo Zhao; Yi Ding; Yu Zeng; Bin Xue; Guangming Wang; Fangce Wang; Xiu Luo; Aibin Liang; Ellen L. Weisberg; Wenjun Zhang; Wenchao Lu; Jing YangShow moreShow less
Affiliations
1. Department of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Shanghai Key Laboratory of Signaling and Disease Research, School of Life Sciences and Technology, Tongji University, Shanghai, China; 2. Lingang Laboratory, Shanghai, China; 3. Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; 4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; 5. Department of Medicine, Harvard Medical School, Boston, USAShow moreShow less
61
days
Emerging venetoclax plus hypomethylating agent-based triplet regimens in newly diagnosed acute myeloid leukemia: updates from the 2025 ASH Annual Meeting
Authors
Haibo Yu; Ting Shi; Hong-Hu ZhuShow moreShow less
Affiliations
1. Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; 2. Chinese Institutes for Medical Research, Beijing, China; 3. Institute for Cancer, Chinese Institutes for Medical Research (CIMR), Beijing, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days